FOXO Technologies Inc. (FOXO)
AMEX · Common · CUSIP 351471305
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for FOXO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
351471305 (prev. 351471107 )
Market Cap
Micro Cap
IPO
12/11/2020
Previous Symbol
DWIN (changed 9/26/2022)
Previous Name
Delwinds Insurance Acquisition Corp.
Business: FOXO Technologies Inc. is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO seeks to modernize the life insurance industry by simplifying the consumer underwriting journey with saliva-based biomarkers and enhancing life insurance’s consumer value proposition with the FOXO Longevity Report.
Notes: October 27, 2023 -- Technologies Inc., a leader in the field of commercializing epigenetic biomarker technology, today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company’s Class A common stock, par value $0.0001 (the “Common Stock”). The reverse stock split will become effective at 4:01pm ET on November 6, 2023. The Common Stock is expected to begin trading on a split-adjusted basis on the NYSE American under the same symbol “FOXO” when the market opens on November 7, 2023, with the new CUSIP number 351471305.

Company Contact

CEO
Tyler Danielson
CFO
Robby Potashnick
Headquarters
477 South Rosemary Avenue, Suite 224, West Palm Beach, FL 33401
Phone
612-800-0059 · Toll-Free 888-925-1803
Investor Relations
Matthew Hausch, Gateway Investor Relations · 949-574-3860 · FOXO@gatewayir.com
General Email
info@foxotechnologies.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »
Find all related securities for FOXO »